Jennifer Lloyd Halsey

Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis.

Founded in 1992, Asante Partners LLC is a broker/dealer located in New York City with an additional office in Menlo Park, California. They provide investment banking and strategic advisory services to companies across all sectors of healthcare, with particular expertise in mergers and private equity financing. They specialize in pharmaceuticals, medical technology, devices, biotechnology, drug delivery systems, services, information technology and diagnostics

Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Proton Solutions segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA.

Metra Biosystems Inc was a leader in developing and commercializing diagnostic products for the detection and management of metabolic bone diseases and disorders. The company's strategy is to offer a portfolio of tests that will provide physicians with comprehensive clinical information regarding the metabolism of bone and other connective tissues

InNeuroCo, Inc. develops and manufactures neurovascular products for hemorrhagic stroke. It offers intermediate catheters and super distal access (SDA) device for insertion procedures. The company was founded by Marc Litzenberg and Daniel Sablyak in 2014 and is headquartered in Sunrise, FL.